Hapoalim Cutting Ocverage On Multitude Of Names

Hapoalim Securities announced it would be terminating coverage of a slew of pharmaceutical names due to an analyst departure. The names affected are Bristol-Myers BMY, Eli Lilly LLY Merck MRK Pfizer PFE Acorda ACOR, Alkermes ALKS Amarin AMRN Amylin AMLN Arena Pharmaceuticals ARNA, Auxilium AUXL, Biospecifics BSTC, Cephalon CEPH, MannKind MNKD, Medivation MDVN, Nektar NKTR, Neurocrine Biosciences NBIX, Protalix PLX Targacept TRGT, and Vanda Pharmaceuticals VNDA.